BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25861792)

  • 1. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation.
    Nguyen SD; Javanainen M; Rissanen S; Zhao H; Huusko J; Kivelä AM; Ylä-Herttuala S; Navab M; Fogelman AM; Vattulainen I; Kovanen PT; Öörni K
    J Lipid Res; 2015 Jun; 56(6):1206-21. PubMed ID: 25861792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
    Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
    J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes of apoB-100 in SMase-modified LDL mediate formation of large aggregates at acidic pH.
    Sneck M; Nguyen SD; Pihlajamaa T; Yohannes G; Riekkola ML; Milne R; Kovanen PT; Oörni K
    J Lipid Res; 2012 Sep; 53(9):1832-9. PubMed ID: 22717515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein aggregation is inhibited by apolipoprotein J-derived mimetic peptide D-[113-122]apoJ.
    Rivas-Urbina A; Rull A; Montoliu-Gaya L; Pérez-Cuellar M; Ordóñez-Llanos J; Villegas S; Sánchez-Quesada JL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158541. PubMed ID: 31672573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
    Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
    Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
    J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for the protective effects of low-density lipoprotein receptor-related protein 1 (LRP1)-derived peptides against LDL aggregation.
    Benitez-Amaro A; Pallara C; Nasarre L; Rivas-Urbina A; Benitez S; Vea A; Bornachea O; de Gonzalo-Calvo D; Serra-Mir G; Villegas S; Prades R; Sanchez-Quesada JL; Chiva C; Sabido E; Tarragó T; Llorente-Cortés V
    Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1302-1316. PubMed ID: 31077676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
    Tabas I; Li Y; Brocia RW; Xu SW; Swenson TL; Williams KJ
    J Biol Chem; 1993 Sep; 268(27):20419-32. PubMed ID: 8376399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic roles of lipoprotein lipase and sphingomyelinase in low density lipoprotein aggregation.
    Walters MJ; Wrenn SP
    J Colloid Interface Sci; 2011 Nov; 363(1):268-74. PubMed ID: 21839462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
    Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
    J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycans.
    Bancells C; Benítez S; Ordóñez-Llanos J; Öörni K; Kovanen PT; Milne RW; Sánchez-Quesada JL
    J Biol Chem; 2011 Jan; 286(2):1125-33. PubMed ID: 21078674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
    Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
    Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
    Paananen K; Kovanen PT
    J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?
    Kinnunen PK; Holopainen JM
    Trends Cardiovasc Med; 2002 Jan; 12(1):37-42. PubMed ID: 11796243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-Ketocholesterol.
    Maor I; Mandel H; Aviram M
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1378-87. PubMed ID: 7670952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis and fusion of low density lipoprotein particles strengthen their binding to human aortic proteoglycans.
    Paananen K; Saarinen J; Annila A; Kovanen PT
    J Biol Chem; 1995 May; 270(20):12257-62. PubMed ID: 7744877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice.
    Maor I; Hayek T; Hirsh M; Iancu TC; Aviram M
    Atherosclerosis; 2000 May; 150(1):91-101. PubMed ID: 10781639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.
    Plihtari R; Hurt-Camejo E; Oörni K; Kovanen PT
    J Lipid Res; 2010 Jul; 51(7):1801-9. PubMed ID: 20124257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-4F, an apolipoprotein A-I mimetic peptide, protects human umbilical vein endothelial cells from oxidized low-density lipoprotein-induced injury by preventing the downregulation of pigment epithelium-derived factor expression.
    Liu J; Yao S; Wang S; Jiao P; Song G; Yu Y; Zhu P; Qin S
    J Cardiovasc Pharmacol; 2014 Jun; 63(6):553-61. PubMed ID: 24709637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans.
    Hakala JK; Oörni K; Pentikäinen MO; Hurt-Camejo E; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1053-8. PubMed ID: 11397719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.